Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide for low-grade duodenal inflammation in functional dyspepsia
2020-002593-27Phase 4Active
- Sponsor
- UZ Leuven
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of budesonide in functional dyspepsia (FD), sponsored by UZ Leuven. Primary endpoint: Duodenal eosinophils. Started Apr 2022; status: active.
02
Drugs
budesonide
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2020-002593-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002593-27.